Coromandel International Limited has acquired an additional 0.67% stake in NACL Industries Limited through participation in the company's rights issue, as disclosed in regulatory filings submitted to stock exchanges on January 4, 2026.

Acquisition Details

The acquisition involved 1,88,24,301 equity shares completed on December 31, 2025, through subscription to the rights issue including additional shares. As the promoter of NACL Industries, Coromandel International's participation demonstrates continued commitment to the target company.

Shareholding Changes

The transaction resulted in a marginal increase in Coromandel's ownership percentage in NACL Industries. The company's shareholding position shows steady promoter participation in the rights offering.

Regulatory Compliance

The disclosure was filed under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquisition was made pursuant to exemption provided under Regulation 10(4)(a) and (b), which covers rights issue subscriptions by existing shareholders.

Exchange Listings

Both companies are listed on BSE Limited and National Stock Exchange of India Limited. Coromandel International trades under symbol COROMANDEL (NSE) and scrip code 506395 (BSE), while NACL Industries trades under symbol NACLIND (NSE) and scrip code 524709 (BSE), ensuring proper regulatory oversight of the transaction.

Transaction Impact

The acquired shares represent a significant absolute number but resulted in only a marginal percentage increase due to the overall expansion of NACL Industries' share capital through the rights issue. The acquisition reinforces Coromandel's position as the promoter while maintaining compliance with all applicable regulations.

NACL Industries Limited has published its post-issue advertisement regarding the successful completion of its ₹249 crore rights issue, marking the final regulatory step following the allotment process completed on December 31, 2025. The company issued the advertisement on January 2, 2026, in compliance with SEBI regulations.

Rights Issue Completion Summary

The company successfully completed the allotment of 3.25 crore rights equity shares at ₹76.70 per share, raising approximately ₹249 crore through its rights issue. The Securities Issue Committee approved the allotment on December 31, 2025, with the entire process conducted in consultation with KFin Technologies Limited as the registrar.

Subscription and Allotment Details

The rights issue received overwhelming response from investors, with the company receiving 9,916 applications for 64,500,791 rights equity shares. After technical rejections of 674 applications, 9,242 valid applications were processed for 64,016,879 shares, representing 196.96% subscription of the issue size.

Post-Issue Regulatory Compliance

The post-issue advertisement was published in multiple newspapers including Financial Express (all editions), Jansatta (all editions), and Surya (Hyderabad editions) on January 2, 2026. This publication fulfills the requirements under Regulation 92(1) of the SEBI ICDR Regulations.

Capital Structure Enhancement

Following the successful allotment, NACL Industries' paid-up equity share capital increased from ₹20.15 crore to ₹23.40 crore, representing an addition of ₹3.25 crore through the new share issuance.

Subsidiary Investment Approval

The Securities Issue Committee also approved a ₹83 crore investment in wholly-owned subsidiary NACL Spec-Chem Limited through Compulsorily Convertible Debentures (CCDs), with 8,300 debentures of ₹1 lakh face value each for loan repayment purposes.

The successful completion of this rights issue and subsequent regulatory compliance positions NACL Industries for enhanced operational capabilities while demonstrating strong investor confidence in the agro-chemical sector company's growth prospects.